CML Developing Three Years after Therapy Completion in a Child with Ph(−) Pre-B-ALL
We report a girl with a history of Ph(−) pre-B-ALL and three years of disease-free survival admitting to our hospital for regular end of treatment checkup with an increased white blood cell count which in follow-up studies and molecular detection of BCR-ABL (p210) fusions gene had been diagnosed as...
Saved in:
Main Authors: | S. Hosseini, G. H. Bahoush, P. Vousogh, Sh. Ansari, Kh. Arjmandi, M. Sabzechian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2011/670603 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course
by: Angela McLigeyo, et al.
Published: (2020-01-01) -
Aplasia in Chronic Phase CML Post-TKI Therapy: A Management Dilemma
by: Jeremy L. Ramdial, et al.
Published: (2019-01-01) -
Management of Metachronous Bilateral Testis Cancer in a Patient with Pre-B Cell ALL
by: Kelly T. Harris, et al.
Published: (2015-01-01) -
MiCML: a causal machine learning cloud platform for the analysis of treatment effects using microbiome profiles
by: Hyunwook Koh, et al.
Published: (2025-01-01) -
A 54-Year-Old Woman with Donor Cell Origin of Multiple Myeloma after Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of CML
by: Erika Maestas, et al.
Published: (2016-01-01)